1,7-phenanthroline has been researched along with Bone Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Northcote-Smith, J; Passeri, G; Singh, K; Suntharalingam, K; Vincent, RA | 1 |
| Deng, KK; Guo, QF; Li, XY; Liu, QH; Liu, SH; Wang, JW; Wu, HF; Wu, Y; Xu, HH; Zhao, JH; Zhu, JW | 1 |
2 other study(ies) available for 1,7-phenanthroline and Bone Neoplasms
| Article | Year |
|---|---|
The Osteosarcoma Stem Cell Activity of a Gallium(III)-Phenanthroline Complex Appended to Salicylate.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cyclooxygenase 2; Gallium; Humans; Osteosarcoma; Phenanthrolines; Salicylates; Stem Cells | 2022 |
Effect of radiation on cytotoxicity, apoptosis and cell cycle arrest of human osteosarcoma MG-63 induced by a ruthenium(II) complex.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Coordination Complexes; Humans; Membrane Potential, Mitochondrial; Osteosarcoma; Phenanthrolines; Reactive Oxygen Species; Ruthenium | 2015 |